ConvaTec Group completes acquisition of Triad Life Sciences
ConvaTec Group Plc (CTEC:LON) is pleased to announce that it has completed the acquisition of Triad Life Sciences Inc (‘Triad’). The Triad team, current portfolio and product pipeline will now transition to ConvaTec’s Advanced Wound Care (AWC) business and be known as ConvaTec Advanced Tissue Technologies. Learn More >>
Triad Life Sciences® introduces InnovaMatrix® Technology Platform, a next-generation extracellular matrix (ECM) product that advances the science of the wound management, burn care, and surgical markets by combining the technological advantages of a medical device – reliability, reproducibility, and a rigorous safety profile – with the inherent, natural benefits found within the placenta.
Triad Life Sciences® is dedicated to increasing patient access to innovative, reliable, and accessible technologies that address complex surgical wounds, chronic stalled wounds, burns, and other regenerative dermal applications.
Next-Generation Wound Treatment